Evidence map›Paper›PMID 42608630›Full record

ArticleJournal of cancer survivorship : research and practice2026

Prevalence and associated factors of poor lifestyle behaviours in survivors of childhood cancer: a PanCareFollowUp substudy.

Selina R van den Oever, Leontien C M Kremer, Helena J H van der Pal, Mieke Rijken, Gisela Michel, Andrea Beccaria, Eline Bouwman, Jeroen Te Dorsthorst, Samira Essiaf, Elizabeth Lieke A M Feijen and 24 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Selina R van den OeverPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. s.r.vandenoever-2@prinsesmaximacentrum.nl.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Helena J H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Mieke RijkenNetherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
Gisela MichelUniversity of Lucerne, Lucerne, Switzerland.
Andrea BeccariaDivision of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Eline BouwmanRadboud University Medical Centre, Nijmegen, The Netherlands.
Jeroen Te DorsthorstPanCare, Bussum, The Netherlands.
Samira EssiafEuropean Society for Pediatric Oncology (SIOP Europe), Brussels, Belgium.
Elizabeth Lieke A M FeijenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Cecilia FollinLund University, Skåne University Hospital, Lund, Sweden.
Line Elmerdahl FrederiksenChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Hannah GsellCCI Europe, Vienna, Austria.
Maria van HelvoirtKatholieke Universiteit Leuven, Leuven, Belgium.
Rosella P M G HermensDivision of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Lars HjorthLund University, Skåne University Hospital, Lund, Sweden.
Tomas KepakInternational Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
Katerina KepakovaInternational Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
Anita KienesbergerCCI Europe, Vienna, Austria.
Marietta KoklaChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Monica MuracaDivision of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Kylie O'BrienPintail Limited, Dublin, Ireland.
Marleen RenardCCI Europe, Vienna, Austria.
Katharina RoserUniversity of Lucerne, Lucerne, Switzerland.
Carina SchneiderCCI Europe, Vienna, Austria.
Roderick SkinnerGreat North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom.
Ramona TalloneDivision of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Anne UyttebroeckKatholieke Universiteit Leuven, Leuven, Belgium.
Deveny VanrusseltKatholieke Universiteit Leuven, Leuven, Belgium.
Sabine VerschuerenKatholieke Universiteit Leuven, Leuven, Belgium.
Jeanette Falck WintherChildhood Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Jacqueline LoonenRadboud University Medical Centre, Nijmegen, The Netherlands.
Saskia M F PluijmPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. s.m.f.pluijm@prinsesmaximacentrum.nl.
PanCareFollowUp Consortium

Funding

Horizon 2020 No 824982
6 · The paper itself

Abstract

purposePoor lifestyle behaviours may contribute to the development or worsening of late effects after childhood cancer. The aims of this study were to determine the baseline prevalence and associated factors of poor lifestyle behaviours among childhood cancer survivors of the European PanCareFollowUp study cohort.

methodsIn Belgium, Sweden, Czechia, and Italy, 812 childhood cancer survivors were recruited. Outcomes were self-reported poor lifestyle behaviours, defined as low physical activity (<75 min of vigorous or <150 min of moderate to vigorous physical activity per week), current smoking (yes/no), alcohol consumption (≥3 units of alcohol per week), and drug use in the past year (yes/no). The prevalence of poor lifestyle behaviours was calculated and associations with sociodemographic characteristics, cancer history, physical health, pain, fatigue, and survivors' level of empowerment were estimated using multivariable logistic regression analyses.

resultsFor these analyses, 777 participants were included, of whom 27% of survivors reported low physical activity, 15% smoked, 19% consumed ≥3 units of alcohol per week, and 9% used drugs in the past year. The smoking prevalence differed per country and was highest among survivors from Czechia (23%) and Italy (22%) and lowest in Belgium (10%) and Sweden (5%). Associated factors with any of the four poor lifestyle behaviours included male sex, lower educational attainment, reduced physical health, pain, and fatigue.

conclusionsStudy results show that survivors in each of the four countries may benefit from personalised interventions to promote healthier behaviours, and that reduced physical health, pain, and fatigue may present modifiable targets. IMPLICATIONS FOR CANCER SURVIVORS: These findings can be used to develop targeted lifestyle interventions, thereby optimising survivors' lifestyle behaviours, health outcomes, and quality of life.

Indexed as

BehaviourLifestyleLong-term follow-up carePaediatric oncologyPanCareFollowUpSurvivorship

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.